Skip to main content

peptidepro.ai

Menu
For Practitioners
Home / FAQs

Frequently asked questions

Common questions about our editorial approach, evidence standards, and scope.

No. PeptidePro.ai has no commercial relationships with peptide manufacturers, compounding pharmacies, or supplement companies. We do not sell products, accept affiliate revenue, or link to sellers. Our funding model is disclosed on our About page.

All topic guides are authored by science writers with relevant graduate degrees and reviewed by our medical advisory board, which includes board-certified physicians and clinical researchers. Every guide carries a named reviewer byline with credentials and date of last review.

Dosing protocols for unapproved compounds carry regulatory and safety risks that exceed the scope of an educational resource. We provide mechanism of action, evidence summaries, and clinical considerations. Dosing decisions belong in the practitioner-patient relationship.

We use a four-tier framework adapted from GRADE methodology: High, Moderate, Low, and Very Low confidence. The level reflects the quality, quantity, and consistency of published evidence, not our editorial opinion. Pre-clinical data alone receives a Very Low rating regardless of how many animal studies exist.

The content is written at a practitioner level. While you are welcome to reference our materials in clinical discussions, we recommend adapting the language and level of detail for patient communication.

Some reference summaries and literature reviews use AI-assisted tools for initial drafting and citation retrieval. All clinical claims, evidence grades, and conclusions are verified against primary sources by human reviewers before publication.